
On December 28, the 2022 Academic Annual Meeting of the National Clinical Research Center for Radiology and Interventional Therapy was held in Conference Room 1 of the Shanghai World Expo Exhibition Hall, adopting a hybrid format combining online and offline participation.
As one of the key highlights of the annual conference,Shenzhen Aibo Medical Robotics Co., Ltd. (hereinafter referred to as: Aibo Medical Robotics) and the National Clinical Research Center for Radiology and Interventional Medicine (hereinafter referred to as: the National Center) regarding “Strategic Cooperation for the Joint Development of Pan-Vascular Interventional Surgical Robots"Hold a grand launch ceremony."
Attendees at the launch ceremony included Professor Wang Xin, Party Secretary of Zhongshan Hospital Fudan University; Professor Zhou Jian, Vice President; Professor Qian Juying, Vice President; and three clinical principal investigators (PIs) from Aibo Medical Robotics.Academician Ge Junbo, Professor Liu Jianmin, and Professor Fu Weiguo, as well as Dr. Guo Jian, General Manager of the Company, and Dr. Ren Wenyong, Deputy General Manager. Academician Guo Shuxiang, Chairman of Aibo Medical Robotics Co., Ltd., delivered a cooperation address online.

Professor Shen Li Presides Over the Launch Ceremony of the Strategic Cooperation
The strategic cooperation launch ceremony is scheduled to take place after the opening of the annual conference and the address by the leadership of Zhongshan Hospital. It mainly consists of three segments: an introduction to the background of the bilateral cooperation, the launch ceremony, and remarks from representative experts.
The launch ceremony for the strategic partnership was hosted by Professor Shen Li, Director of the Office of the National Clinical Research Center for Radiology and Interventional Therapy. Professor Shen stated that the collaboration between the National Clinical Research Center for Radiology and Interventional Therapy and Shenzhen Aibo Medical Robot Co., Ltd. is grounded in a shared philosophical foundation.in the field of pan-vascular interventional surgical robots, both partiesDesign and Development, Animal Testing, and Clinical StudiesPreliminary results have been achieved in cooperation in areas such as.
Professor Shen Li also stated that, as a pioneer in pan-vascular interventional surgical robots, Aibo Medical Robotics is a high-tech enterprise co-founded by Academician Guo Shuxiang, an expert under the Overseas High-Level Talent Introduction Program, and his team. As a representative of China’s vascular interventional surgical robotics industry, the company’s further collaboration with our institution holds significant strategic importance.
Leaders and Experts from Both Sides Jointly Launch Strategic Cooperation Ceremony
After introducing the background of the collaboration, moderator Professor Shen Li invitedShanghaiZhongshan HospitalSecretary Wang Xin, Vice President Zhou Jian, Vice President Qian Juying, Academician Ge Junbo, Professor Liu Jianmin, Professor Fu Weiguo, Professor Yang Pengfei, Professor Si Yi, Dr. Guo Jian, Dr. Ren WenyongAs the expert representatives took the stage, everyone jointly pressed the button, witnessed by all guests both online and offline,"Strategic Cooperation for the Joint Development of Pan-Vascular Interventional Surgical Robots"Glory Launch.

Academician Ge Junbo Delivers Opening Remarks
Subsequently, Academician Ge Junbo took the stage to deliver remarks on the collaboration. He stated that since the partnership began, both parties have established a strong consensus and shared vision in the fields of "pan-vascular medicine" and the development of interventional surgical robots. He expressed his hope that the team wouldDeepen integration and participation in the development of Aibo Medical's robots to create a pan-vascular interventional surgical robot with fully independent intellectual property rights that meets physicians' clinical needs.. Meanwhile,He is willing to collaborate with Academician Guo Shuxiang’s team to develop pan-vascular interventional surgical robots, drive industry advancement, and hopes that Aibo Medical Robotics will become China’s representative in the field of pan-vascular interventional surgical robots.

Academician Guo Shuxiang Publishes an Open Letter toResignation
Finally, the conference connected live with Academician Guo.Academician Guo on"Pan-Vascular Interventional Surgical Robot"Address at the Launch of the Joint Development Strategic Partnership. Academician Guo Shuxiang expressed his great honor in witnessing this launch ceremony. He introduced the practices and achievements of the Aibo Medical Robotics team in the field of “cardiovascular and cerebrovascular interventional surgical robots,” shared his outlook on this strategic cooperation, and encouraged both teams to work together diligently to create a truly “User-Centric” pan-vascular interventional surgical robot. Meanwhile, we extend our gratitude to the guests who attended the strategic cooperation launch ceremony, and we wish the 2022 Annual Academic Conference of the National Clinical Research Center for Radiology and Interventional Medicine every success.

2022 Academic Annual Meeting of the National Clinical Research Center for Radiology and Interventional Medicine
The National Clinical Research Center for Radiology and Interventional Medicine is a national clinical medical research center accredited by the Ministry of Science and Technology, the National Health Commission, the Logistics Support Department of the Central Military Commission, and the National Medical Products Administration. According to Academician Ge Junbo, the National Center will be developed around five key directions and objectives: 1) establishing a national-level interventional base and platform; 2) promoting multicenter clinical research and technologies; 3) building regional medical consortiums and network systems; 4) constructing a system for translating scientific and technological innovations into practical applications; and 5) formulating world-class international standards for interventional techniques.
The launch of this strategic partnership marks that Aibo Medical Robotics will join hands with the National Clinical Research Center for Radiology and Interventional Medicine, a national-level clinical research platform,with the clinical principal investigator (PI) expert team comprising Academician Ge Junbo, Professor Fu Weiguo, and Professor Liu JianminComprehensive and in-depth collaboration in product development, animal studies, human clinical trials, and training and promotion of pan-vascular interventional surgical robots, jointly creating a pan-vascular interventional surgical robot with global innovation attributes and promoting the development of China's vascular interventional surgical robot industry.
About Aibo Medical Robotics
Shenzhen Aibo Medical Robot Co., Ltd. (hereinafter referred to as “Aibo Medical Robot”) is a high-tech enterprise specializing in medical robots, founded by Professor Guo Shuxiang—a distinguished expert under the Overseas High-Level Talent Introduction Program, foreign member of the Engineering Academy of Japan, and IEEE Fellow—and his team. The company’s core technological achievements stem from projects under China’s National “863 Program.” As of October 2022, the company had filed more than 300 intellectual property rights, including Chinese invention patents and international patents, with multiple original technologies reaching internationally leading levels.The company has partnered with a renowned domestic clinical expert team in the field of vascular intervention and has received investment from multiple top-tier venture capital firms.
